Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4437 |  IGC IGC Pharma, Inc. Common Stock | 0.30 USD | -3.23% | +7.14% | +15.38% | +15.38% | 31.02 M USD | ||
| 4450 |  ACTU Actuate Therapeutics, Inc. - Common stock | 1.26 USD | -0.79% | +23.53% | +4.13% | -69.12% | 30.26 M USD | ||
| 4452 |  KYNB Kyntra Bio, Inc. - Common Stock | 7.68 USD | +2.13% | +11.30% | +9.25% | -19.24% | 31.10 M USD | ||
| 4460 |  LTRN Lantern Pharma Inc. - Common Stock | 2.16 USD | -7.69% | -13.94% | -22.02% | -48.45% | 27.61 M USD | ||
| 4462 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 0.72 USD | 0.00% | -8.86% | -36.28% | -61.50% | 29.61 M USD | ||
| 4463 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 1.20 USD | -4.76% | -7.69% | -26.83% | -67.57% | 28.12 M USD | ||
| 4474 |  NXTC NextCure, Inc. - Common Stock | 5.94 USD | -5.56% | -23.55% | +38.79% | -54.66% | 27.19 M USD | ||
| 4476 |  NNVC NanoViricides, Inc. Common Stock | 1.30 USD | -1.52% | -4.41% | -15.03% | +28.71% | 28.14 M USD | ||
| 4482 |  EVAX Evaxion A/S - American Depositary Share | 3.30 USD | -0.30% | -0.60% | +10.37% | -0.60% | 27.52 M USD | ||
| 4489 |  LGVN Longeveron Inc. - Class A Common stock | 0.85 USD | +1.19% | +6.25% | +46.55% | +49.12% | 27.10 M USD | ||
| 4496 |  GRDX GridAI Technologies Corp. - Common Stock | 3.60 USD | +0.84% | -12.20% | +13.92% | +41.18% | 25.67 M USD | ||
| 4499 |  ATOS Atossa Therapeutics, Inc. - Common Stock | 2.46 USD | -3.15% | -5.02% | +6.96% | +211.39% | 24.55 M USD | ||
| 4500 |  BRNS Barinthus Biotherapeutics plc - American Depositary Shares | 0.63 USD | +1.61% | +5.00% | +5.00% | -49.19% | 25.73 M USD | ||
| 4504 |  DYAI Dyadic International, Inc. - Common Stock | 0.72 USD | +4.35% | -5.26% | -38.46% | -20.00% | 26.24 M USD | ||
| 4506 |  BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.79 USD | -1.25% | -14.13% | -7.06% | -50.00% | 24.73 M USD | ||
| 4507 |  CVM Cel-Sci Corporation Common Stock | 1.40 USD | -1.41% | -7.89% | +20.69% | -72.82% | 24.62 M USD | ||
| 4510 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.80 USD | -3.23% | -5.26% | -27.71% | -50.00% | 24.01 M USD | ||
| 4513 |  OABIW OmniAb, Inc. - Warrant | 0.2339 USD | +37.59% | -19.34% | +283.44% | +37.10% | 34.01 M USD | ||
| 4517 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.58 USD | -0.39% | -1.90% | +6.61% | -17.83% | 24.39 M USD | ||
| 4523 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.68 USD | -5.56% | -16.05% | -1.45% | -76.95% | 22.63 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |